For the NCI-H526 xenograft model, complete tumor regressions were observed in mice receiving 10 mg/kg and 5 mg/kg promiximab-DUBA and no regrowth were observed in a long term after termination of the treatment. Here, OTUD5 is linked to neoplasm.